A case of simultaneous occurrence of hepatitis and pancreatitis during the combination immunochemotherapy for non-small cell lung carcinoma

A case of simultaneous occurrence of hepatitis and pancreatitis during the combination immunochemotherapy for non-small cell lung carcinoma

Immune checkpoint inhibitors (ICIs) improved the prognosis of patients with advanced lung cancers. The combination therapy of cytotoxic drugs and ICI is approved as first-line chemotherapy in non-small-cell lung cancer (NSCLC) and extensive disease small-cell lung cancer (ED-SCLC). It has been repor...

Full description

Bibliographic Details
Main Authors: Satoshi Tanaka, Ryo Asakawa, Kiyohide Komuta, Satoshi Tanizaki, Tomohiro Kanai, Muneyoshi Kuroyama, Kohki Shimazu, Junji Uchida, Takayuki Yakushijin, Kiyonobu Ueno
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Immune checkpoint inhibitors (ICIs)
Combination immunochemotherapy
Immune-related adverse events (irAEs)
Hepatitis
Pancreatitis
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007120304809

Internet

http://www.sciencedirect.com/science/article/pii/S2213007120304809

Similar Items